Re: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
9
|
Resverlogix Corp.
|
Sep 18, 2020 08:43AM
|
Re: OUCH!!! Things Move Faster In The Cancer Arena and Other Gems
|
4
|
Zenith Epigenetics
|
Sep 17, 2020 04:10PM
|
Re: OUCH!!! Things Move Faster In The Cancer Arena and Other Gems
|
3
|
Zenith Epigenetics
|
Sep 17, 2020 02:59PM
|
Re: OUCH!!! Things Move Faster In The Cancer Arena and Other Gems
|
3
|
Zenith Epigenetics
|
Sep 17, 2020 02:13PM
|
Re: SF
|
7
|
Resverlogix Corp.
|
Sep 17, 2020 11:41AM
|
Re: SF
|
5
|
Resverlogix Corp.
|
Sep 16, 2020 11:47AM
|
Re: Option #2
|
6
|
Resverlogix Corp.
|
Sep 11, 2020 07:04AM
|
Re: guesses as to when our partner(s)/deal will be announced?
|
1
|
Resverlogix Corp.
|
Aug 23, 2020 02:58PM
|
Re: TD Zenith Capital Corp | Grey Market : ZHCLF
|
2
|
Zenith Epigenetics
|
Aug 18, 2020 04:32PM
|
Re: Why is "Going it Alone" out of the question??
|
2
|
Resverlogix Corp.
|
Aug 18, 2020 02:05PM
|
Follow the smart money??
|
3
|
Resverlogix Corp.
|
Aug 16, 2020 11:25AM
|
Re: Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics
|
3
|
Resverlogix Corp.
|
Aug 04, 2020 05:03PM
|
Re: Thinking back on an older discussion and wishing we had an update - Few items
|
10
|
Resverlogix Corp.
|
Jul 26, 2020 08:11PM
|
Re: Report of exempt distribution
|
4
|
Resverlogix Corp.
|
Jul 01, 2020 06:54PM
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
6
|
Resverlogix Corp.
|
Jun 22, 2020 06:41PM
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
9
|
Resverlogix Corp.
|
Jun 13, 2020 12:06PM
|
Re: Still waiting for that BETonMACE CKD sub-study 7 months later
|
5
|
Resverlogix Corp.
|
Jun 12, 2020 10:23AM
|
Re: Led Gac
|
3
|
Resverlogix Corp.
|
Jun 08, 2020 05:03PM
|
Re: Resverlogix Announces Corporate Update Conference Call...
|
3
|
Resverlogix Corp.
|
Jun 06, 2020 09:30AM
|
Re: Pfizer
|
5
|
Zenith Epigenetics
|
Jun 05, 2020 03:48PM
|